CLOs on the Move

Civica Rx

www.civicarx.org

 
Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q2 2023, we have provided over 125 million units of essential medicines to hospitals, enough to help treat over 50 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more than $30 a vial and no more than $55 for ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.civicarx.org
  • 2912 Executive Parkway
    Lehi, UT USA 84043
  • Phone: 888.304.0120

Executives

Name Title Contact Details
Seth Randle
 Vice President, Legal Profile
Patrick Higgins
 Associate General Counsel Profile
Sarah McGonigle
 Associate General Counsel Profile
Sarah McGonigle
 Chief Ethics and Compliance Officer and Profile
Antonia Giuliana
 Associate General Counsel Profile

Similar Companies

Asymchem Laboratories

Asymchem Laboratories is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alkem Laboratories

Alkem Laboratories is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India.

Clearworth Systems

Clearworth Systems is a Rumson, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phathom Pharmaceuticals

Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.

Fujirebio Europe